DBV Technologies SA DBV

European equities traded in the US as American depositary receipts were falling sharply late Thursda

European equities traded in the US as American depositary receipts were trending lower late Wednesda

Châtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years The BLA is supported by the results from the successful Phase 3 VITESSE trial – the largest immunotherapy clinical trial to date for this population. DBV has requested Priority Review of the BLA. DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, tod

European equities traded in the US as American depositary receipts were tracking slightly lower Thur

European equities traded in the US as American depositary receipts were tracking lower Wednesday mor

European equities traded in the US as American depositary receipts were heading lower late Friday mo

European equities traded in the US as American depositary receipts were rising sharply late Thursday

European equities traded in the US as American depositary receipts edged higher late Wednesday morni

European equities traded in the US as American depositary receipts were heading lower late Tuesday m

European equities traded in the US as American depositary receipts opened the week tracking sharply

European equities traded in the US as American depositary receipts were trending higher late Friday

European equities traded in the US as American depositary receipts were trending lower late Thursday

European equities traded in the US as American depositary receipts were marginally higher late Frida

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 DateTotal number of sharesTotal number of voting rights08/31/2026 314,388,807 Total gross of voting rights: 314,388,807 Total net* of voting rights: 314,222,095 * Net total = total number of voting rights attached to shares – shares without vo

European equities traded in the US as American depositary receipts were trending slightly higher lat

European equities traded in the US as American depositary receipts were marginally higher late Frida

European equities traded in the US as American depositary receipts were marginally higher late Tuesd

European equities traded in the US as American depositary receipts were tracking higher late Thursda